Identifying the Gaps in the Diagnosis and Management of Hepatitis C
NCT00976781 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-04-05
Summary
The purpose of this study is to identify the gaps in diagnosing and managing hepatitis C infected patients so that interventions can be targeted to address these problem areas in order to optimize care of these patients.
Conditions
- Hepatitis C
Sponsors & Collaborators
-
Henry Ford Health System
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2009-04-30
- Completion
- 2009-04-30
Countries
- United States
Study Locations
More Related Trials
-
The Pathogenesis of Hepatitis C Virus Vertical Transmission
NCT01921400 ·Status: COMPLETED
-
Anticipated and Perceived Benefits Following Hepatitis C Treatment
NCT03000023 ·Status: COMPLETED
-
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
NCT02641158 ·Status: COMPLETED ·Phase: NA
-
Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients
NCT00871845 ·Status: TERMINATED ·Phase: NA
-
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
NCT02006823 ·Status: COMPLETED
-
ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing
NCT03767231 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection
NCT02597166 ·Status: COMPLETED ·Phase: PHASE3
-
Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection
NCT02707991 ·Status: COMPLETED ·Phase: NA
-
Chronic Hepatitis C and Insulin Resistance
NCT00707603 ·Status: COMPLETED
-
Examining Hepatitis C Reinfection Rates in Kenya
NCT03564639 ·Status: COMPLETED
-
Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 B
NCT01429155 ·Status: COMPLETED
-
Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C
NCT02123212 ·Status: COMPLETED ·Phase: NA
-
Improving Fibrosis Outcomes With Metformin
NCT02306070 ·Status: WITHDRAWN ·Phase: PHASE2
-
Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs
NCT03170076 ·Status: UNKNOWN
-
HCV Virions Bound Proteins
NCT02795403 ·Status: COMPLETED ·Phase: NA
-
Overcoming Psychiatric Barriers to the Treatment of Hepatitis C
NCT00407732 ·Status: COMPLETED ·Phase: NA
-
Screening, Treatment, and Eradication of Hep C
NCT05071261 ·Status: NOT_YET_RECRUITING
-
Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1
NCT03245931 ·Status: COMPLETED
-
Hepatitis C Virus (HCV) Treatment Completion or Withdrawal
NCT00674492 ·Status: COMPLETED
-
A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C
NCT01705717 ·Status: COMPLETED
-
Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment
NCT01329952 ·Status: UNKNOWN
-
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
NCT01474811 ·Status: COMPLETED
-
Re-linkage to Care of Patients With Hepatitis C
NCT04470271 ·Status: UNKNOWN
-
Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors
NCT01813266 ·Status: WITHDRAWN
-
Hepatitis C Treatment and Atherosclerosis
NCT00659256 ·Status: COMPLETED